<DOC>
	<DOCNO>NCT02145572</DOCNO>
	<brief_summary>The purpose study identify unique metabolite signature associate development Type 2 diabetes diabetic kidney disease child . We sub-study , purpose validate presence genetic marker ( DENND1A ) urine adolescent female polycystic ovarian syndrome .</brief_summary>
	<brief_title>Metabolomic Profiling Adolescents With Obesity Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Age 1319 year Gender : male female Ethnic background : Obesity define BMI &gt; 95th percentile age/gender Diagnosis diabetes define current American Diabetes Association criterion Diabetes duration &lt; 2.5 year Absence pancreatic autoimmunity ( GAD65 ICA512 Insulin autoantibody ) Adult caregiver willing actively support study participation Signed parental inform consent form adolescent assent form For PCOS substudy , diagnosis PCOS define accord 1990 US National Institute Health ( NIH ) criterion ( oligomenorrhea , clinical biochemical sign hyperandrogenism , exclusion know disorder ) Creatinine clearance &lt; 60 mL/min ( calculate estimate GFR ) Other significant organ system illness condition ( include psychiatric developmental disorder ) , opinion investigator , would prevent participation . For PCOS substudy , use medication effect androgen level blood ( i.e . oral contraceptive pill , metformin ) last 3 month prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>